150 related articles for article (PubMed ID: 8935845)
1. The amyloidoses.
Buxbaum J
Mt Sinai J Med; 1996 Jan; 63(1):16-23. PubMed ID: 8935845
[No Abstract] [Full Text] [Related]
2. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.
Sipe JD; Benson MD; Buxbaum JN; Ikeda SI; Merlini G; Saraiva MJ; Westermark P
Amyloid; 2016 Dec; 23(4):209-213. PubMed ID: 27884064
[TBL] [Abstract][Full Text] [Related]
3. Amyloidosis: a clinico-pathophysiological synopsis.
Hirschfield GM
Semin Cell Dev Biol; 2004 Feb; 15(1):39-44. PubMed ID: 15036205
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
[TBL] [Abstract][Full Text] [Related]
5. Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.
Hesse A; Altland K; Linke RP; Almeida MR; Saraiva MJ; Steinmetz A; Maisch B
Br Heart J; 1993 Aug; 70(2):111-5. PubMed ID: 8038017
[TBL] [Abstract][Full Text] [Related]
6. A-V block as presentation of cardiac amyloid: prominent infiltration of conduction tissue revealed by endomyocardial biopsy.
Frustaci A; Letizia C; Adamo F; Grande C; Verardo R; Chimenti C
Amyloid; 2017 Jun; 24(2):131-132. PubMed ID: 28488941
[No Abstract] [Full Text] [Related]
7. AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.
Penchala SC; Connelly S; Wang Y; Park MS; Zhao L; Baranczak A; Rappley I; Vogel H; Liedtke M; Witteles RM; Powers ET; Reixach N; Chan WK; Wilson IA; Kelly JW; Graef IA; Alhamadsheh MM
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9992-7. PubMed ID: 23716704
[TBL] [Abstract][Full Text] [Related]
8. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
Connors LH; Prokaeva T; Lim A; Théberge R; Falk RH; Doros G; Berg A; Costello CE; O'Hara C; Seldin DC; Skinner M
Am Heart J; 2009 Oct; 158(4):607-14. PubMed ID: 19781421
[TBL] [Abstract][Full Text] [Related]
9. [Familial amyloidosis].
Grateau G; Roux ME
Presse Med; 1992 Nov; 21(37):1768-73. PubMed ID: 1488422
[TBL] [Abstract][Full Text] [Related]
10. Human brain amyloidoses.
Gambetti P; Russo C
Nephrol Dial Transplant; 1998; 13 Suppl 7():33-40. PubMed ID: 9870435
[No Abstract] [Full Text] [Related]
11. Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.
Buxbaum JN; Ruberg FL
Genet Med; 2017 Jul; 19(7):733-742. PubMed ID: 28102864
[TBL] [Abstract][Full Text] [Related]
12. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
Maurer MS; Hanna M; Grogan M; Dispenzieri A; Witteles R; Drachman B; Judge DP; Lenihan DJ; Gottlieb SS; Shah SJ; Steidley DE; Ventura H; Murali S; Silver MA; Jacoby D; Fedson S; Hummel SL; Kristen AV; Damy T; Planté-Bordeneuve V; Coelho T; Mundayat R; Suhr OB; Waddington Cruz M; Rapezzi C;
J Am Coll Cardiol; 2016 Jul; 68(2):161-72. PubMed ID: 27386769
[TBL] [Abstract][Full Text] [Related]
13. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).
Bhuiyan T; Helmke S; Patel AR; Ruberg FL; Packman J; Cheung K; Grogan D; Maurer MS
Circ Heart Fail; 2011 Mar; 4(2):121-8. PubMed ID: 21191093
[TBL] [Abstract][Full Text] [Related]
14. Age-related oxidative modifications of transthyretin modulate its amyloidogenicity.
Zhao L; Buxbaum JN; Reixach N
Biochemistry; 2013 Mar; 52(11):1913-26. PubMed ID: 23414091
[TBL] [Abstract][Full Text] [Related]
15. Transthyretin amyloidosis: a tale of weak interactions.
Saraiva MJ
FEBS Lett; 2001 Jun; 498(2-3):201-3. PubMed ID: 11412857
[TBL] [Abstract][Full Text] [Related]
16. Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports.
Jacobson DR; Ittmann M; Buxbaum JN; Wieczorek R; Gorevic PD
Tex Heart Inst J; 1997; 24(1):45-52. PubMed ID: 9068139
[TBL] [Abstract][Full Text] [Related]
17. [Classification of amyloidosis].
Misumi Y; Ando Y
Brain Nerve; 2014 Jul; 66(7):731-7. PubMed ID: 24998818
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
Ruberg FL; Maurer MS; Judge DP; Zeldenrust S; Skinner M; Kim AY; Falk RH; Cheung KN; Patel AR; Pano A; Packman J; Grogan DR
Am Heart J; 2012 Aug; 164(2):222-228.e1. PubMed ID: 22877808
[TBL] [Abstract][Full Text] [Related]
19. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.
Jacobson DR; Pastore RD; Yaghoubian R; Kane I; Gallo G; Buck FS; Buxbaum JN
N Engl J Med; 1997 Feb; 336(7):466-73. PubMed ID: 9017939
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin Cardiac Amyloidosis in Black Americans.
Shah KB; Mankad AK; Castano A; Akinboboye OO; Duncan PB; Fergus IV; Maurer MS
Circ Heart Fail; 2016 Jun; 9(6):e002558. PubMed ID: 27188913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
